pharma-company /Medicinal products /Active ingredients

Rx · PZN 17955364

HEMLIBRA 30 mg/ml solution for injection 12mg-0,4ml vial

German trade nameHEMLIBRA 30 mg-ml Injektionslösung 12mg-0,4ml Durchstechflasche

Active ingredientEmicizumabPharmaceutical formSolution for injection/infusion

Only sporadically available

1.5

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €477

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for HEMLIBRA 30 mg/ml solution for injection 12mg-0,4ml vial.

Review purchasing terms

HEMLIBRA 30 mg/ml solution for injection 12mg-0,4ml vial contains the active ingredient Emicizumab and comes as Solution for injection/infusion. One pack size is recorded (PZN 17955364). The pharma availability index for German wholesale stands at 1.5 out of 10 over the past 30 days – the pack was therefore only sporadically available.


HEMLIBRA 30 mg/ml solution for injection 12mg-0,4ml vial was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.